The Canadian Agency for Drugs and Technologies in Health (CADTH) has published the CADTH Pharmaceutical Reviews Update. This is a new consolidated publication that will communicate updates to the CADTH's drug review process. It replaces previous individual publications, including the CDR Update, the pCODR Update, the Therapeutic Review Update and Updates for Patient Groups.
Among other things, the first issue of the CADTH Pharmaceutical Reviews Update invites stakeholder comments on a number of proposals and announces changes to the Pan-Canadian Oncology Drug Review.
For further information on this topic please contact Urszula Wojtyra at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email ([email protected]). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
This article was first published by the International Law Office, a premium online legal update service for major companies and law firms worldwide. Register for a free subscription.
